The Gold Standard in Rheumatoid Arthritis

Rodnan G.P. , Benedek T.G. The early history of antirheumatic drugs. Arthritis Rheum 1970; 13: 145–65

Forestier J. Rheumatoid arthritis and its treatment by gold salts. J Lab Clin Med 1935; 20: 827–40

Empire Rheumatism Council. Gold therapy in rheumatoid arthritis, final report of a multicentre controlled trial. Ann Rheum Dis 1961; 20: 315–34

Bombardier C. , Ware J. , Russell I.J. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Am J Med 1986; 81: 565–78

Page F. Treatment of lupus erythematosus with mepacrine. Lancet 1951; ii: 755–758

Freedman A. , Steinberg V.I. Chloroquine in rheumatoid arthritis. A double-blindfold trial of treatment for one year. Ann Rheum Dis 1960; 19: 243–50

Hamilton E.B.D. , Scott J.T. Hydroxychloroquine sulfate (“Plaquenil”) in treatment of rheumatoid arthritis. Arthritis Rheum 1962; 5: 502–12

Zvaifler N.J. Antimalarial treatment of rheumatoid arthritis. Med Clin North Am 1968; 52: 759–64

Marsman C.D.G. , Livesey S.J. , Jessop J.D. , Mills P.V. , Richards I. Screening for hydroxychloroquine retinal toxicity: Is it necessary? Eye 1990; 4: 572–6

Multicentre trial group. Controlled trial of D(–)penicillamine in severe rheumatoid arthritis. Lancet 1973; i: 275–80

Lipsky P.E. Mechanism of action of slow-acting drugs in rheumatoid arthritis. Clin Exp Rheumatol 1989; 7: 177–80

Situyanake R.D. , Grindulis K.A. , McConkey B. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Ann Rheum Dis 1987; 46: 177–80

Capell H.A. , Marabani M. , Madhok R. , Torley H. , Hunter J.A. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period. Q J Med 1990; 75: 335–44

Englert H.J. , Hughes G.R.V. , Walport M.J. Sulphasalazine and regression of rheumatoid nodules. Ann Rheum Dis 1987; 46: 244–5

Van der Heijde D.M. , van Riel P.L. , Nuver-Zwart H.H. , Gribnau F.W. , van de Putte L.B. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989; i: 1036–8

Maini R.N. Heberden Oration 1988. Exploring immune pathways in rheumatoid arthritis. Br J Rheumatol 1989; 28: 466–79